Pharmacogenomics

Clinical Case Applicationsin Pharmacogenomics (Part 2)
CME (AMA PRA Category 1 Credits™) 2.0; ACPE 2.0(UAN:0853-9999-17-048-L01-P) 2.0

Sunday, October 8
10:00 AM - 12:00 PM

Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, has reached the translational stage for various specialties in medicine. Over thirty years of research has led to promising advances in the clinical practice. This conference provides the background, resources and practical application examples to implement pharmacogenomics and make a difference in patient lives. Mayo Clinic experts, with experience leading the implementation of PGx, will provide practical guidance on a range of topics, background and research including: when to order testing, drug/gene selection, informatics, and case study working sessions.

8:00 am Welcome and Review
8:15 am Systems & Tools for Implementation - Wayne (Nick) T. Nicholson, MD, PhD
8:55 am Q&A
9:05 am Research in Pharmacogenomics - Eric Matey, PharmD, RPh
9:35 am Q&A
9:45 am Break
Case Series II
10:00 am Gastroenterology - Jo Giri
11:00 am HIV - John D. Zeuli, PharmD, RPh
12:00 Noon Luncheon
Case Series III
1:00 pm Cancer/TPMT - Richard Weinshilboum, MD
2:00 pm HLA(Gout)/Predictive/Preventive - Wayne (Nick) T. Nicholson, MD, PhD
3:00 pm Break
Case Series IV
3:15 pm Transplant - Christopher B. Grilli, PharmD, RPh
4:15 pm Psych - Adrijana Kekic, PharmD
5:15 pm Closing Comments and Adjourn

Learning Objectives:

Fadi Shamoun

Cardiovascular Diseases; Department of Internal Medicine; Assistant Professor of Medicine, Mayo Clinic College of Medicine
Mayo Clinic Division of Cardiovascular Diseases

Presentation(s):

Send Email for Fadi Shamoun

John Zeuli

Ambulatory Care Pharmacist - Mayo HIV Clinic;Pharmacist - Mayo Clinic Center for Tuberculosis
Mayo Clinic

John Zeuli, PharmD, BCPS, is an infectious diseases specialist pharmacist. He currently works seeing patients in the ambulatory setting in Mayo's HIV clinic, and he provides pharmacy consultation services for the Mayo Clinic Center for Tuberculosis. He completed his PGY1 pharmacotherapy residency at Mayo Clinic in 2008 and his PGY2 infectious diseases specialty pharmacy practice residency at Mayo Clinic in 2009. He worked at Mayo Clinic Hospital as a clinical pharmacist in internal medicine from 2009-2013 before taking his current position in 2013. His interests include applied pharmacogenomics, pharmacokinetics, therapeutic drug monitoring, pharmacotherapy of tuberculosis, and HIV antiretroviral therapy.

Presentation(s):

Send Email for John Zeuli


Assets

Clinical Case Applicationsin Pharmacogenomics (Part 2)
CME (AMA PRA Category 1 Credits™) 2.0; ACPE 2.0(UAN:0853-9999-17-048-L01-P) 2.0



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Clinical Case Applicationsin Pharmacogenomics (Part 2)
CME (AMA PRA Category 1 Credits™) 2.0; ACPE 2.0(UAN:0853-9999-17-048-L01-P) 2.0